Percheron Therapeutics (PERCF) Financial Statements
Percheron Therapeutics Financial Overview
Percheron Therapeutics's market cap is currently $4.18M. The company's EPS TTM is $-0.00; its P/E ratio is -0.73; Percheron Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -219.56K | $ -67.98K | $ -79.42K | $ -95.20K | $ -89.22K |
| Operating Income | $ -5.62M | $ -16.71M | $ -14.88M | $ -13.34M | $ -7.61M |
| EBITDA | $ -5.40M | $ -16.27M | $ -11.84M | $ -13.25M | $ -7.52M |
| Net Income | $ -4.79M | $ -14.92M | $ -11.92M | $ -11.38M | $ -5.81M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 4.05M | $ 10.17M | $ 11.87M | $ 10.97M | $ 19.23M |
| Total Assets | $ 8.22M | $ 12.44M | $ 14.53M | $ 12.84M | $ 22.44M |
| Total Debt | $ 27.79K | $ 25.86K | $ 39.87K | $ 142.10K | $ 227.40K |
| Net Debt | $ -2.52M | $ -10.14M | $ -11.83M | $ -10.83M | $ -19.01M |
| Total Liabilities | $ 692.18K | $ 2.43M | $ 5.17M | $ 2.87M | $ 1.30M |
| Stockholders' Equity | $ 7.53M | $ 10.00M | $ 9.36M | $ 9.98M | $ 21.14M |
| Cash Flow | |||||
| Free Cash Flow | $ -4.97M | $ -15.65M | $ -10.12M | $ -8.18M | $ -7.81M |
| Operating Cash Flow | $ -4.96M | $ -15.64M | $ -10.12M | $ -8.15M | $ -7.81M |
| Investing Cash Flow | $ -3.09M | $ -7.24K | $ -3.61K | $ -29.29K | $ -3.91K |
| Financing Cash Flow | $ 1.93M | $ 13.95M | $ 11.02M | $ -85.30K | $ 21.02M |
Currency in AUD